Olivia C Ware
Director at Contineum Therapeutics, Inc. (CTNM)
Olivia C Ware has filed 20 insider reports with the SEC since March 2021, as director at Contineum Therapeutics, Inc. (CTNM), director at Arcellx, Inc. (ACLX) and director at Revance Therapeutics, Inc. (RVNC). Olivia C Ware made no open-market purchases or sales in the last 12 months. The latest filing, on June 26, 2026, reports grant or award at Contineum Therapeutics, Inc. (CTNM).
- Filings
- 20
- Companies
- 3
- Bought on market
- None
- Sold on market
- $1.16M
Companies where Olivia C Ware is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | $9.04 | Jun 26, 2026 | |||||
| Directorsince May 2022 | 0 | $1.16M | Apr 28, 2026 | ||||
| Directorsince March 2021 | 0 | Feb 6, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 26, 2026CTNMSEC Form 4 filed by Director Ware Olivia CForm 4Grant or award
- Apr 28, 2026ACLXSEC Form 4 filed by Director Ware Olivia CForm 4Sale back to the company
- Jun 26, 2025CTNMSEC Form 4 filed by Director Ware Olivia CForm 4Grant or award
- May 29, 2025ACLXSEC Form 4 filed by Director Ware Olivia CForm 4Grant or award
- Feb 6, 2025RVNCDirector Ware Olivia C returned 15,000 shares to the company, closing all direct ownership in the companyForm 4Sale back to the companyTender of shares in a change of control
- May 28, 2024ACLXSEC Form 4 filed by Ware Olivia CForm 4Grant or award
- May 24, 2024CTNMSEC Form 4 filed by Ware Olivia CForm 4Grant or award
- May 1, 2024RVNCWare Olivia C was granted 15,000 shares, increasing direct ownership by 90% to 31,675 unitsForm 4Grant or award
- Apr 16, 2024-$522KACLXWare Olivia C exercised 9,402 shares at a strike of $7.61 and sold $522,260 worth of shares (9,402 units at $55.55)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 15, 2024-$634KACLXWare Olivia C exercised 9,000 shares at a strike of $7.61 and sold $633,582 worth of shares (9,000 units at $70.40)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 15, 2024~$1.28MACLXOlivia C Ware plans to sell 18,402 shares (~$1.28M)Form 144Planned sale10b5-1 plan
- Jun 14, 2023ACLXSEC Form 4 filed by Ware Olivia CForm 4Grant or award
- May 3, 2023RVNCSEC Form 4 filed by Ware Olivia CForm 4Grant or award
- May 16, 2022ACLXSEC Form 4 filed by Ware Olivia CForm 4Grant or award
- May 16, 2022ACLXOlivia C Ware became an insiderForm 3New insider
- May 4, 2022RVNCSEC Form 4 filed by Ware Olivia C (Amendment)Form 4Grant or award
- May 4, 2022RVNCSEC Form 4: Ware Olivia C was granted 6,059 shares, increasing direct ownership by 86% to 13,141 unitsForm 4Grant or award
- May 5, 2021RVNCSEC Form 4: Ware Olivia C was granted 674 units of Common Stock, increasing direct ownership by 11% to 7,082 unitsForm 4Grant or award
- Mar 8, 2021RVNCSEC Form 4: C Olivia Ware was granted 6,408 units of Common StockForm 4Grant or award
- Mar 6, 2021RVNCSEC Form 3 filed by C Olivia WareForm 3New insider
Compare Olivia C Ware with
- Olivia C Ware vs Carmine N. Stengone1 shared
- Olivia C Ware vs Daniel S. Lorrain1 shared
- Olivia C Ware vs Tim Watkins1 shared
- Olivia C Ware vs Gines Diego Miralles1 shared
- Olivia C Ware vs Lori Lyons-Williams1 shared
- Olivia C Ware vs Evert B. Schimmelpennink1 shared
Other insiders at the same companies
- Carmine N. StengoneCTNM
- Daniel S. LorrainCTNM
- Tim WatkinsCTNM
- Gines Diego MirallesCTNM
- Lori Lyons-WilliamsCTNM
- Evert B. SchimmelpenninkCTNM
- Troy A. IgnelziCTNM
- Todd R. BradyCTNM
- Sarah BoyceCTNM
- Jill CarrollACLX
- Ali BehbahaniACLX
- Kavita PatelACLX
- Kristin MyersACLX
- David Charles LubnerACLX
- Andrew H GalliganACLX
- Michelle GilsonACLX
Questions about Olivia C Ware
- What is Olivia C Ware's role at Contineum Therapeutics, Inc.?
- Olivia C Ware reports to the SEC as director at Contineum Therapeutics, Inc. (CTNM), according to the latest filing on June 26, 2026. Olivia C Ware has also filed as director at Arcellx, Inc. (ACLX) and director at Revance Therapeutics, Inc. (RVNC).
- Has Olivia C Ware bought or sold stock recently?
- The most recent open-market sale was on April 16, 2024: sold 9,402 shares of Arcellx, Inc. (ACLX) for $522K at an average of $55.55.
- How do I get alerts when Olivia C Ware files?
- Follow Olivia C Ware on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Olivia C Ware (SEC CIK 0001663771). Totals count each trade once, skipping amendments whose original is on file, from Mar 10, 2021 on. View on SEC EDGAR · Get this as JSON